Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule

NCT00572000 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

222

Enrollment

OTHER_GOV

Sponsor class

Conditions

Human Papillomavirus (HPV) Vaccine

Interventions

BIOLOGICAL: HPV-16/18 L1 VLP AS04 vaccine

Sponsor

National Institute for Control of Vaccine and Biologicals